Finance
why Apellis Pharmaceuticals Inc [APLS] is a Good Choice for Investors After New Price Target of $81.66
Apellis Pharmaceuticals Inc [NASDAQ: APLS] loss -7.63% or -3.65 points to close at $44.19 with a heavy trading volume of 6668101 shares. The daily chart for APLS points out that the company has recorded -7.05% loss over the past six months. If we look at
